...
机译:在非可选肝细胞癌常规化疗栓塞后立体定向体放射治疗后更好的存活:倾向评分匹配分析
Univ Hong Kong Dept Surg Hong Kong Peoples R China;
Univ Hong Kong Dept Clin Oncol Hong Kong Peoples R China;
Then Mun Hosp Dept Clin Oncol Hong Kong Peoples R China;
Univ Hong Kong Dept Clin Oncol Hong Kong Peoples R China;
Then Mun Hosp Dept Clin Oncol Hong Kong Peoples R China;
Then Mun Hosp Dept Clin Oncol Hong Kong Peoples R China;
Univ Hong Kong Dept Surg Hong Kong Peoples R China;
Univ Hong Kong Dept Surg Hong Kong Peoples R China;
Univ Hong Kong Dept Surg Hong Kong Peoples R China;
Univ Hong Kong Dept Surg Hong Kong Peoples R China;
Univ Hong Kong Dept Surg Hong Kong Peoples R China;
Then Mun Hosp Dept Clin Oncol Hong Kong Peoples R China;
Univ Hong Kong Dept Clin Oncol Hong Kong Peoples R China;
Univ Hong Kong Dept Clin Oncol Hong Kong Peoples R China;
Univ Hong Kong Dept Surg Hong Kong Peoples R China;
Hepatocellular carcinoma; Unresectable; Stereotactic body radiation therapy; Transarterial chemoembolization; Outcomes;
机译:在非可选肝细胞癌常规化疗栓塞后立体定向体放射治疗后更好的存活:倾向评分匹配分析
机译:肝切除与立体定向体放射治疗加上大型肝细胞癌的转发动脉化疗:倾向分数分析
机译:大于5?cm的不可切除肝细胞癌经动脉栓塞与立体定向放射疗法联合立体定向放射疗法的长期生存分析
机译:使用3D对比增强超声时间强度曲线分析评估肝细胞癌经动脉化疗栓塞
机译:倍半萜类药物可作为肝细胞癌(HCC)的潜在治疗方法:在大鼠HCC肿瘤模型中,通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
机译:≤5cm肝细胞癌的经动脉化学栓塞与立体定向放射疗法联合经动脉化学栓塞治疗:倾向评分匹配分析
机译:晶促化疗栓塞和立体定向体辐射治疗的组合治疗与≤5CM肝细胞癌的常规化疗栓塞:倾向得分匹配分析